Activation of SGK1/NF- κ B pathway is correlated with low sensitivity to proteasome inhibitors in multiple myeloma Cells

被引：0
|
作者：
Kimura, Akihiro [1 ]
Tsubaki, Masanobu [1 ]
Takeda, Tomoya [1 ]
Matsuda, Takuya [1 ]
Takefuji, Honoka [1 ]
Nishida, Shozo [1 ]
机构：
[1] Kindai Univ, Dept Pharmacotherapy, Fac Pharm, Higashiosaka, Osaka, Japan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3318
引用
收藏
页码：1989 / 1989
页数：1
相关论文
共 50 条
  • [1] Overexpression of SGK1 is involved with proteasome inhibitor resistance in multiple myeloma
    Kimura, Akihiro
    Tsubaki, Masanobu
    Takeda, Tomoya
    Matsuda, Takuya
    Yamamoto, Yuuta
    Nishida, Shozo
    CANCER SCIENCE, 2022, 113 : 1049 - 1049
  • [2] Herbacetin Inhibits Asthma Development by Blocking the SGK1/NF-κB Signaling Pathway
    Chen, Xiufeng
    Jiang, Yong hong
    Fei, Xiaoqin
    Wang, Mingjing
    Liu, Anqi
    Li, Xuejun
    Jiang, Zhiyan
    JOURNAL OF ASTHMA AND ALLERGY, 2024, 17 : 703 - 716
  • [3] Classical and/or alternative NF-κB pathway activation in multiple myeloma
    Demchenko, Yulia N.
    Glebov, Oleg K.
    Zingone, Adriana
    Keats, Jonathan J.
    Bergsagel, P. Leif
    Kuehl, W. Michael
    BLOOD, 2010, 115 (17) : 3541 - 3552
  • [4] A salvage pathway of SGK1 in eNOS activation in coronary cells
    Pastore, D.
    Della Morte, D.
    Capuani, B.
    Pacifici, F.
    Coppola, A.
    Arriga, R.
    Bellia, A.
    Tesauro, M.
    Donadel, G.
    Sconocchia, G.
    Sbraccia, P.
    Lauro, D.
    DIABETOLOGIA, 2016, 59 : S507 - S507
  • [5] SGK1 is involved in doxorubicin-induced chronic cardiotoxicity and dysfunction through activation of the NFκB pathway
    Zhang, Yu
    Zhang, Dan
    Meng, Tingting
    Tian, Peng
    Chen, Jianlin
    Liu, Anbang
    Zheng, Yan
    Su, Guohai
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 125
  • [6] Factors determining the sensitivity to proteasome inhibitors of multiple myeloma cells
    Pelon, Marta
    Krzeminski, Patryk
    Tracz-Gaszewska, Zuzanna
    Misiewicz-Krzeminska, Irena
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [7] SGK1 contributes to ferroptosis in coronary heart disease through the NEDD4L/NF-κB pathway
    Peng, Yong
    Jiang, Yu
    Zhou, Qingfeng
    Jia, Zheng
    Tang, Han
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2024, 196
  • [8] A new structural class of proteasome inhibitors that prevent NF-κB activation
    Lum, RT
    Kerwar, SS
    Meyer, SM
    Nelson, MG
    Schow, SR
    Shiffman, D
    Wick, MM
    Joly, A
    BIOCHEMICAL PHARMACOLOGY, 1998, 55 (09) : 1391 - 1397
  • [9] Activation of Serum/Glucocorticoid Regulated Kinase 1/Nuclear Factor-κB Pathway Are Correlated with Low Sensitivity to Bortezomib and Ixazomib in Resistant Multiple Myeloma Cells
    Tsubaki, Masanobu
    Takeda, Tomoya
    Matsuda, Takuya
    Seki, Shiori
    Tomonari, Yoshika
    Koizumi, Shoutaro
    Nagatakiya, Miki
    Katsuyama, Mai
    Yamamoto, Yuuta
    Tsurushima, Katsumasa
    Ishizaka, Toshihiko
    Nishida, Shozo
    BIOMEDICINES, 2021, 9 (01) : 1 - 20
  • [10] SGK1 induces vascular smooth muscle cell calcification through NF-κB signaling
    Voelkl, Jakob
    Luong, Trang T. D.
    Tuffaha, Rashad
    Musculus, Katharina
    Auer, Tilman
    Lian, Xiaoming
    Daniel, Christoph
    Zickler, Daniel
    Boehme, Beate
    Sacherer, Michael
    Metzler, Bernhard
    Kuhl, Dietmar
    Gollasch, Maik
    Amann, Kerstin
    Mueller, Dominik N.
    Pieske, Burkert
    Lang, Florian
    Alesutan, Ioana
    JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (07): : 3024 - 3040
12345